A suite of
White Holmusk Logo
solutions

The Behavioral Health Data Platform That Serves Your Mission.

BEHAVIORAL HEALTH

Research-Grade

Real-world data

From neuropsychiatric drug discovery to patient care delivery, we transform behavioral health data into actionable insights.
OUR DATA

Powering analysis with deeper granularity

NeuroBlu Data is the largest source of real-world behavioral and mental health data - longitudinal and NLP enriched to unlock clinical insights.

Leading Source for
Behavioral & Mental Health
Real-World Data
36,500,000+

Patients

40+

Geographically-diverse health systems

20+

Years of longitudinal data

Linkability

Connects patient data across time and care settings to enable longitudinal analysis and richer clinical insights.

Longitudinal

Over 20 years of behavioral health data from diverse care environments including inpatient, outpatient, emergency, crisis, and community settings.

Comprehensive

Combines structured data with NLP-enriched clinical notes to support multidimensional cohort development and outcomes research.

Depth

Offers validated behavioral health variables—assessments, symptoms, testing, and interventions—for advanced analytics and decision-making.

FIND OUT MOREREQUEST A DEMO
SOLUTIONS

NeuroBlu Solutions

NeuroBlu platform seamlessly connects our behavioral health data and analytics capabilities with our behavioral health expertise to bring specialized solutions to customers across the healthcare ecosystem.

Suite

Best-in-class data,
delivered how you choose

We recognize that diverse behavioral health challenges require tailored solutions.

Neuropsych Analytics for Life Sciences &
Researchers
Access insights in just a few clicks with our user-friendly data analytics software, complete with no-code analytics capabilities and pre-designed study templates so you get the answers you need faster.
Behavioral Health Care Management &
Population Health Solution
Unlock structured EHR data to deliver fast, actionable insights. Built with providers and system leaders, it supports proactive, evidence-based decisions that improve outcomes, reduce costs, and keep data secure within the provider’s environment.
Reimagining Behavioral Health supporting graphic
Reimagining Behavioral Health supporting graphic

Leverage user-friendly tools within the NeuroBlu data analytics platform to easily explore and analyze data and draw new insights to address your toughest behavioral health challenges.

Learn More

Reimagining Behavioral Health supporting graphic

NeuroBlu Health is a behavioral health care management and analytics solution that leverages NeuroBlu’s robust database to provide clinicians with valuable data-driven recommendations, assisting clinicians in making patient-specific care decisions in behavioral health.

NeuroBlu Health is equipped with user-friendly tools that streamline care management processes, freeing up clinicians to devote their time and resources to patients.

Learn More

Reimagining Behavioral Health supporting graphic
the urgent need

Behavioral health disorders are a defining problem of our generation.

Behavioral health is a fundamental and persistently overlooked aspect of overall health. Mental and substance use disorders impact a staggering 970 million people worldwide, with over US $1 trillion in global economic burden each year. Despite the skyrocketing crisis, progress has lagged behind other disease areas. Less than half of those living with major depression, the most widespread mental illness, reach remission on currently available treatments. Recent rising awareness has driven demand in a system unequipped to support the depth and breadth of need.

There is a debilitating evidence gap that inhibits research and innovation, stemming from inherent limitations in behavioral health: complex disease etiologies, lack of quantifiable biomarkers, and institutional silos. Despite decades of research, we still do not know how to alleviate most behavioral health disorders.

We need new solutions, and we need them now.

Value

Accelerating treatments,
improving outcomes

Trusted by stakeholders committed to improving behavioral health through better evidence.

R&D for Drug Development

  • Optimize trial design by leveraging data on symptoms and outcomes (e.g. PHQ-9 or MSE) to identify patients in the real-world who meet study criteria
  • Validate design assumptions by tracking real-world outcomes of patient cohorts

  • Advance drug development by identifying new indications and label expansion opportunities for marketed products

Medical Affairs

  • Characterize the disease burden and unmet needs within specific subpopulations of behavioral health patients
  • Generate evidence to illustrate treatment gaps and how emerging therapies help bridge these gaps
  • Identify patients most likely to benefit for newly approved or launched drugs

Market Access and HEOR

  • Obtain advanced characterization of factors that may inhibit success, such as predictors of poor outcomes, lack of tolerability, adherence to treatment, etc.
  • Inform value proposition and product positioning by understanding real-world utilization patterns and unmet needs throughout product lifecycle
  • Identify patient segments that are eligible for new drugs and use real-world evidence to inform formulary decision-making

Payors and Value-Based Care

  • Monitor behavioral health utilization with NeuroBlu Analytics to optimize management strategies and understand patient journeys
  • Evaluate real-world outcomes over time to measure the comparative effectiveness of treatments and guide value-based contracting
  • Identify high-risk patients with NeuroBlu Analytics' predictive insights for early interventions

Healthcare Managers and Providers

  • Reduce avoidable cost of care through behavioral health-specific risk detection and patient complexity insights to identify potential crises early and intervene before escalation
  • Improve care operations through data-driven workload balancing, streamlined care coordination, and reduced administrative burden
  • Advance quality of care by identifying and closing gaps in care, monitoring outcomes across settings, and support continuous quality improvement initiatives
EXPLORE USE CASES
OUR Work

Unlocking new insights

NeuroBlu has supported diverse stakeholders produce publication-ready behavioral health research, including collaborative projects with:

Otsuka Pharmaceutical Co., Ltd.

Analyzed healthcare resource utilization rates for patients with schizophrenia and bipolar disorder; work was published in Current Medical Research and Opinion

Read More

Cytel

Created, trained, and tested a predictive model to better understand indicators of increased hospitalization risk for patients with major depressive disorder; work was presented at ISPOR Europe

Read More

JPS Health Network

Explored factors that impact attrition from treatment in patients with opioid use disorder; work was published inNeuropsychiatric Disease and Treatment

Read More

Code Templates

Analytics Tools

Research-Grade EHR

Reimagining Behavioral Health supporting graphic
THE BLUEPRINT

Reimagining Behavioral Health

NeuroBlu is a data and analytics platform that enables uniquely powerful evidence generation. With the most robust behavioral health database of its kind and seamless AI-powered analytic tools, NeuroBlu gives researchers, life sciences companies, clinicians, and other industry partners the ability to generate insights like never before.

More than just an analytics platform, NeuroBlu enables discovery to improve lives.

Behavioral health transformation starts here.

ENRICHMENT

Uncovering Real-World
Insights with NLP

check icon

Over 300 psychiatry-specific labels

check icon

NLP model trained on notes from over 11,000 clinicians and 6 million data points

check icon

Disease severity score for most encounters

Our novel Natural Language Processing (NLP) algorithm transforms rich clinician notes into structured data that predicts disease severity.

Clinician notes are valuable troves of information on patient experience, treatment response, and outcomes that are not captured in other EHR or claims data sources. Analyzing unstructured notes is typically arduous and time-consuming.

Our proprietary NLP model unlocks insights from clinician notes, allowing for large-scale analysis and disease modeling. We have over 300 psychiatry-specific structured labels on granular symptoms, side effects, external stressors, and more. These labels can also be used to predict disease severity based on CGI-S scores, opening up a new frontier for scalable analysis of patient experiences through clinician notes.

Going beyond standard context-aware keyword search NLP approaches, our proprietary NLP models are designed specifically to handle the complexity of psychiatric care, which lacks standardized terminology and relies heavily on subjective assessments and verbose descriptions. Our NLP approach leverages the latest innovation in machine learning and language modeling to interpret full sentences using an attention based deep learning, producing granular structured data labels.

check icon

Over 300 psychiatry-specific labels

check icon

NLP model trained on notes from over 11,000 clinicians and 6 million data points

check icon

Disease severity score for every encounter

Features

Accelerate Evidence Generation with Fast, Scalable Studies

Designed by a team of scientists, clinicians, and industry experts, NeuroBlu's robust tools drive Real-World Evidence generation with unparalleled ease.

NeuroBlu's custom-built architecture brings the power of high-performance computing and innovation to real-world studies. User-friendly tools streamline typically laborious and error-prone analysis steps, enabling users to get to insights without having to spend hours cleaning data and troubleshooting code. Built-in custom libraries let you use the data with ease - no need to spend hours navigating a complex data model, because our data scientists did it for you.

Data Explorer showcasing multiple number of data tables available,

View data and get high-level summaries of the dataset, including a set of visualizations describing the population characteristics

Cohort Builder interface with updated statistics based on the user's cohort selection.

Intuitive graphical interface allowing you to build your study cohort using a few clicks, and view cohort characteristics with charts updated in real-time

Category Mapper that shows antidepressant drugs selected.

Simple and streamlined tool to build groupings of values (e.g., diagnosis codes or drug type) to create custom categories for use across multiple projects in a simple and less error-prone way

R Code interface that showcases the code panel with different types of files such as 'R', CSV, Image.

Perform custom analytics in R with your own code or from our built-in library of code templates for popular studies

OTHERS

BluSuite

PRO

Perform powerful analyses using Holmusk's proprietary advanced analytics packages, created by our data scientists to provide easy access to frequently used analytics methods such as survival analysis and comparative effectiveness studies

Project Notes

Seamlessly annotate, replicate, and compare results across your research studies with our integrated Project Notes feature, allowing users to write and store research notes

REQUEST A DEMO
Testimonials

What our customers are saying

quote icon

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex.

Jane Doe

Job Role
quote icon

I have people in my family with certain conditions, and with this collaboration we can perhaps change the way behavioral health is treated in the long-term.

Jane Doe

Job Role
quote icon

I have people in my family with certain conditions, and with this collaboration we can perhaps change the way behavioral health is treated in the long-term.

Jane Doe

Job Role
quote icon

I have people in my family with certain conditions, and with this collaboration we can perhaps change the way behavioral health is treated in the long-term.

Jane Doe

Job Role
VIEW ALL
Support

We're Here to Help

We know data is only as useful as its impact. Our team has spent years building expertise in the intricacies of behavioral health data, and we will work collaboratively with you to help generate evidence that matters.

Training and Reference Tools

Rapid onboarding and training with dedicated customer support plus in-depth tutorials and FAQs.

Customer Success

Dedicated support to help you extract the most value from your NeuroBlu license.

Advanced Analytics Services

Tap into our data science and machine learning expertise for custom analytics.

Contact us

Get started with a NeuroBlu Trial

Thank you! We have received your submission. We'll get in touch with you soon.
Latest Announcements

Stay up-to-date with NeuroBlu

New Release

v4.13 – Expanded Cognitive Assessments with 25R2 and Streamlined Data Documentation

May 6, 2025

VIEW

New Release

NeuroBlu Analyticsv4.11 - Density Timeline in Cohort Explorer, SQL Studio v1, SQL Templates for Pharma Depts

March 19, 2025

VIEW

New Release

NeuroBlu Analytics v4.10: 25R1 and Updates to Cohort Explorer - Measurements

February 20, 2025

VIEW
VIEW ALL
Sign Up for NeuroBlu Emails
LATEST ANNOUNCEMENTS
check icon

Over 300 psychiatry-specific labels

check icon

NLP model trained on notes from over 11,000 clinicians and 6 million data points

check icon

Disease severity score for every encounter

VIEW ALL

New Release

PRO

May 6, 2025

General

March 28, 2023

Publication

No items found.
No items found.

Event

December 6, 2022